Literature DB >> 8352258

Evidence for increased cancer deaths in chronic dialysis patients.

K Iseki1, A Osawa, K Fukiyama.   

Abstract

We analyzed longitudinal data on the cancer mortality rate in chronic dialysis patients and in the general population in Okinawa, Japan. In the general population from 1980 to 1990, the mortality rate has been stable at approximately 1.300 males and 0.897 females per thousand persons year, the male to female ratio being 1.45. In the period from 1971 to 1990, we found 91 (4.6%) patients with cancer in a group of 1,982 (824 females and 1,158 males) chronic dialysis patients; forty-nine of the 91 patient (53.8%) died by April 1, 1991. Using the standard mortality rate in the general population, which was obtained for each sex and age class (0 to 34 years, 35 to 44 years, 45 to 54 years, 55 to 64 years, and > or = 65 years), we calculated the relative risk of death from cancer in dialysis patients. The risk ratio in dialysis patients was significantly increased, being 2.48 (P < 0.05) for males and 3.99 (P < 0.05) for females. The mean (+/- SEM) age at the time of death from cancer in the dialysis group was 60.1 +/- 2.0 years in the males and 60.1 +/- 2.1 years in the females; the males were 6.3 years younger than the general population and the females were 9.3 years younger. The proportion of patients with colon cancer (both sexes) and cancer of the uterus and breast (females) was higher in the dialysis patients than in the general population.

Entities:  

Mesh:

Year:  1993        PMID: 8352258     DOI: 10.1016/s0272-6386(12)70323-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

1.  The prevalence of colorectal neoplasia in patients with end-stage renal disease: a case-control study.

Authors:  Sharon Lee; Nir Wasserberg; Patrizio Petrone; Jason Rosca; Rick Selby; Adrian Ortega; Howard S Kaufman
Journal:  Int J Colorectal Dis       Date:  2007-09-13       Impact factor: 2.571

Review 2.  Chronic kidney disease and cancer: a troubling connection.

Authors:  Benedicte Stengel
Journal:  J Nephrol       Date:  2010 May-Jun       Impact factor: 3.902

Review 3.  Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.

Authors:  Hassan Izzedine; Mark A Perazella
Journal:  Nephrol Dial Transplant       Date:  2015-02-03       Impact factor: 5.992

4.  The incidence of urinary tract cancers is related to preserved diuresis: a single-center report.

Authors:  Vedran Premuzic; Marija Gamulin; Marijana Coric; Bojan Jelakovic
Journal:  Int Urol Nephrol       Date:  2017-10-16       Impact factor: 2.370

5.  Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer.

Authors:  Chien-Hui Ou; Wen-Horng Yang
Journal:  Int Urol Nephrol       Date:  2017-02-04       Impact factor: 2.370

6.  The management of well-differentiated thyroid cancer with end-stage renal disease.

Authors:  Tien-Hsiang Wang; Chen-Hsen Lee; Ling-Ming Tseng; Ren-Hsieng Liu
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

7.  Gastrectomy for patients with gastric cancer and non-uremic renal failure.

Authors:  Shozo Mori; Tokihiko Sawada; Kiyoshige Hamada; Junji Kita; Mitsugi Shimoda; Nobumi Tagaya; Keiichi Kubota
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

8.  Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study.

Authors:  Y Hayashino; S Fukuhara; T Akiba; T Akizawa; Y Asano; A Saito; J L Bragg-Gresham; S P B Ramirez; F K Port; K Kurokawa
Journal:  Diabetologia       Date:  2007-03-29       Impact factor: 10.122

9.  CKD and the risk of incident cancer.

Authors:  William T Lowrance; Juan Ordoñez; Natalia Udaltsova; Paul Russo; Alan S Go
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

Review 10.  Noncardiovascular mortality in CKD: an epidemiological perspective.

Authors:  Dinanda J de Jager; Marc G Vervloet; Friedo W Dekker
Journal:  Nat Rev Nephrol       Date:  2014-02-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.